Biotech · Private company · Pasadena, CA, US
Auritec Pharmaceuticals
Track this companyFree. Adds Auritec Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Sustained Release Injectable TacrolimusPhase 1 · Organ Transplant RejectionClinicalTrials.gov · fetched Nov 12, 2026
- TDF IVRPhase 1 · Human Immunodeficiency Virus (HIV) ProphylaxisClinicalTrials.gov · fetched Nov 12, 2026
- TDF-FTC IVRPhase 1 · Human Immunodeficiency Virus (HIV) ProphylaxisClinicalTrials.gov · fetched Nov 12, 2026
- TDF-FTC-MVC IVRPhase 1 · Human Immunodeficiency Virus (HIV) ProphylaxisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human StudyEARLY_PHASE1 · COMPLETED · started Oct 16, 2018ClinicalTrials.gov NCT03626714 · fetched Nov 12, 2026
- Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy WomenEARLY_PHASE1 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02431273 · fetched Nov 12, 2026
NIH awards3
- Long-acting Injectable Brexpiprazole for Agitation in Alzheimer's DementiaFiscal year 2026 · $1MNIH RePORTER 1R44AG102256-01 · fetched Nov 12, 2026
- IND-enabling Preclinical Development of a Sustained-release Pritelivir Intravaginal ring for the Treatment and Prophylaxis of Genital HerpesFiscal year 2025 · $1MNIH RePORTER 5R44AI136201-06 · fetched Nov 12, 2026
- IND-enabling Preclinical Development of a Sustained-release Pritelivir Intravaginal ring for the Treatment and Prophylaxis of Genital HerpesFiscal year 2024 · $1MNIH RePORTER 5R44AI136201-05 · fetched Nov 12, 2026